Muscular dystrophy
In Duchenne muscular dystrophy (DMD), abnormal cardiac function is typically preceded by a decade of skeletal muscle disease. Galindo and colleagues analyzed cardiac and skeletal muscle microarrays from normal and golden retriever muscular dystrophy dogs to gain insight into muscle dysfunction and to identify putative DMD biomarkers. These biomarkers were then measured using human DMD blood samples. The results highlight gene expression patterns that could account for differences in cardiac and skeletal disease. See page 629
Exercise and inflammation
One of the most commonly measured markers of inflammation is C-reactive protein (CRP). This meta-analysis by García-Hermoso et al. examines the evidence of the effectiveness of physical exercise interventions in modifying serum CRP levels in overweight children and adolescents. Nine randomized controlled trials met the inclusion criteria (N = 427 youths). 
Laser measurements of pulmonary oxygen
Pulmonary radiography is part of the clinical routine for diagnosis of respiratory distress syndrome in newborns. Svanberg and colleagues investigated a novel noninvasive technique for rapid, nonradiographic bedside detection of oxygen gas in the lungs of full-term newborn infants. Laser spectroscopy was used to measure oxygen gas and water vapor in the lungs of 29 healthy newborn full-term infants. The skin above the lungs was illuminated using two low-power diode lasers, and diffusely emerging light was detected with a photodiode. The results suggest that, with further development, this method might be implemented in clinical practice for lung monitoring in neonatal intensive care. See page 621
Pediatric Clinical Trials Forum
In November 2014, the American Academy of Pediatrics convened key stakeholders to discuss the feasibility of accelerating medical advances by creating an independent global Pediatric Clinical Trials Network. Such a network would facilitate the development and availability of innovative, high-quality therapies to extend and enhance the lives of neonates, infants, children, adolescents, and young adults. The participants developed a consensus statement expressing their shared vision for the network. See page 662
